Sona Nanotech Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.145
- Today's High:
- $0.145
- Open Price:
- $0.145
- 52W Low:
- $0.049
- 52W High:
- $0.264
- Prev. Close:
- $0.145
- Volume:
- 0
Company Statistics
- Market Cap.:
- $13.35 million
- Book Value:
- 0.026
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- -28.33%
- Return on Equity TTM:
- -74.13%
Company Profile
Sona Nanotech Inc had its IPO on under the ticker symbol SNANF.
The company operates in the Healthcare sector and Diagnostics & Research industry. Sona Nanotech Inc has a staff strength of 0 employees.
Stock update
Shares of Sona Nanotech Inc opened at $0.15 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.15 - $0.15, and closed at $0.15.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Sona Nanotech Inc have increased by +6.62%.
Sona Nanotech Inc's Key Ratios
Sona Nanotech Inc has a market cap of $13.35 million, indicating a price to book ratio of 21.8563 and a price to sales ratio of 0.
In the last 12-months Sona Nanotech Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-948375. The EBITDA ratio measures Sona Nanotech Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Sona Nanotech Inc’s operating margin was 0% while its return on assets stood at -28.33% with a return of equity of -74.13%.
In Q1.3333333333333, Sona Nanotech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Sona Nanotech Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sona Nanotech Inc’s profitability.
Sona Nanotech Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.2627. Its price to sales ratio in the trailing 12-months stood at 0.
Sona Nanotech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $3.60 million
- Total Liabilities
- $510944.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Sona Nanotech Inc ended 2024 with $3.60 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.60 million while shareholder equity stood at $2.43 million.
Sona Nanotech Inc ended 2024 with $0 in deferred long-term liabilities, $510944.00 in other current liabilities, in common stock, $-18672233.00 in retained earnings and $0 in goodwill. Its cash balance stood at $700962.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $653280.00.
Sona Nanotech Inc’s total current assets stands at $842867.00 while long-term investments were $0 and short-term investments were $6000.00. Its net receivables were $112154.00 compared to accounts payable of $397846.00 and inventory worth $0.
In 2024, Sona Nanotech Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Sona Nanotech Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.15
- 52-Week High
- $0.264
- 52-Week Low
- $0.049
- Analyst Target Price
- $
Sona Nanotech Inc stock is currently trading at $0.15 per share. It touched a 52-week high of $0.264 and a 52-week low of $0.264. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.16 and 200-day moving average was $0.13 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 1859.8% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Sona Nanotech Inc
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Sona Nanotech Inc., a nanotechnology life sciences company, engages in developing various rapid diagnostic tests. Its products and services include COVID-19 Saliva Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; and contract services. The company is also involved in developing pre-clinical targeted hyperthermia therapy for colorectal cancer. Sona Nanotech Inc. was founded in 2014 and is based in Halifax, Canada.